Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000042812
- Lead Sponsor
- Edogawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects in whom antidiabetic agents other than GLP-1 RAs or DPP-4 inhibitors were changed during the observation period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c and body weight at 6 months
- Secondary Outcome Measures
Name Time Method